About FDA

NCTR Research Highlights

Red envelope icon for GovdeliveryGet e-mail updates when this information changes.

Current Highlight from August 22, 2014

Bovine Intestinal Bacteria Degrade and Inactivate Ceftiofur

NCTR scientists have shown that ceftiofur—a cephalosporin antimicrobial drug that is approved for veterinary use to treat respiratory disease in cattle, swine, horses, and sheep—is rapidly degraded by bovine intestinal bacteria using a metallo-b-lactamase.  Ceftiofur is structurally similar to the human-use cephalosporin ceftriaxone, and concerns have been raised that use of ceftiofur may adversely impact the effectiveness of other related cephalosporins through the development of antimicrobial resistance.  These results show that bacteria present in the naïve bovine gut are capable of degrading and enzymatically inactivating cephalosporin antimicrobials and reducing environmental exposure to these antimicrobials.  This study is available online at Veterinary Microbiologydisclaimer icon.

For additional information, please contact Bruce Erickson, Ph.D., Staff Fellow, Division of Microbiology, FDA/NCTR.

Contact FDA

National Center for Toxicological Research

Food and Drug Administration

3900 NCTR Road

Jefferson, AR 72079

Page Last Updated: 08/27/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.